Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZL-85FA Tablets in Advanced Solid Tumors (Phase I/IIa, China)
ChiCTR2600119925Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital, Anhui Medical University
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ZL-85FA in Nonhematologic neoplasms, sponsored by The First Affiliated Hospital, Anhui Medical University. Primary endpoint: Objective response rate. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
ZL-85FA
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on ChiCTR2600119925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119925.